RecruitingPhase 2NCT05013892

NTS-WBRT in Brain Metastases

Phase II Trial of Normal Tissue Sparing Whole Brain Radiation Therapy (NTS-WBRT) in Patients With Brain Metastases


Sponsor

Massachusetts General Hospital

Enrollment

41 participants

Start Date

Feb 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This research is being done to assess the quality of life and symptom burden in participants who receive (normal tissue sparing whole brain radiation therapy (NTS-WBRT). This research study involves: * NTS-WBRT (normal tissue sparing whole brain radiation therapy) * Memantine standard of care drug


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a type of whole-brain radiation therapy called neuroprotective hippocampal-sparing WBRT (NTS-WBRT), which is designed to protect the brain's memory center while treating cancer that has spread to the brain. The goal is to preserve memory and thinking skills compared to standard whole-brain radiation. **You may be eligible if...** - You are 18 or older - You have a solid tumor that has spread to the brain (brain metastases) and your doctor recommends whole-brain radiation - Your overall health and function meet certain minimum requirements (Karnofsky score of 70 or above) - You may have had prior brain surgery or focused brain radiation (stereotactic radiosurgery), which is allowed **You may NOT be eligible if...** - Your brain tumor is a primary brain tumor (not a metastasis from another cancer) - You cannot safely receive radiation therapy - Your health status is too poor to tolerate the treatment - Radiation would need to overlap with previously treated brain areas in ways that are not safe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONNTS-WBRT (normal tissue sparing whole brain radiation therapy)

Radiation

DRUGMemantine

Capsule, taken orally


Locations(1)

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05013892


Related Trials